The increasing urgency for standards in basic biologic research

Cancer Research

Volumn 74, Issue 15, 2014, Pages 4024-4029

  Freedman, Leonard P ^a   Inglese, James ^b  

^a Global Biological Standards Institute   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ARTIFACT; BASIC BIOLOGICAL RESEARCH; BASIC RESEARCH; CANCER CELL LINE; CANCER RESEARCH; CONSENSUS; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; IRREPRODUCIBILITY; NONHUMAN; PEER REVIEW; PRECLINICAL RESEARCH; PRIORITY JOURNAL; PUBLICATION; RESEARCH; REVIEW; STANDARD; STATISTICAL PARAMETERS; TRANSLATIONAL RESEARCH; ANIMAL; MEDICAL RESEARCH; METHODOLOGY; REPRODUCIBILITY; STANDARDS;

ANIMALS; BIOMEDICAL RESEARCH; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 84905454415     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-0925     Document Type: Review

References (38)

1. Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature 2012;483:531-3.
2. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 2011;10:712.
3. Mobley A, Linder SK, Braeuer R, Ellis LM, Zwelling L. A survey on data reproducibility in cancer research provides insights into our limited ability to translate findings from the laboratory to the clinic. PLoS ONE 2013;8:e63221.
4. Begley CG. Reproducibility: six red flags for suspect work. Nature 2013;497:433-4.
5. "How science goes wrong?" The Economist October 19, 2013.
6. Christakis DA, Zimmerman FJ. Rethinking reanalysis. JAMA 2013;310:2499-500.
7. Gomez OS, Juristo N, Vegas S. Replication, reproduction and reanalysis: three ways for verifying experimental findings. RESER 2010;35:1-7.
8. GBSI. The case for standards in life science research: seizing opportunities at a time of critical need. Washington, DC: Global Biological Standards Institute 2013.
9. Altshuler JS, Balogh E, Barker AD, Eck SL, Friend SH, Ginsburg GS, et al. Opening up to precompetitive collaboration. Sci Transl Med 2010;2:52cm26.
10. Rubin EH, Gilliland DG. Drug development and clinical trials-the path to an approved cancer drug. Nat Rev Clin Oncol 2012;9:215-22.
11. Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 2012;490:187-91.
12. Zoghbi HY. The basics of translation. Science 2013;339:250.
13. Vasilevsky NA, Brush MH, Paddock H, Ponting L, Tripathy SJ, Larocca GM, et al. On the reproducibility of science: unique identification of research resources in the biomedical literature. PeerJ 2013;1:e148.
14. Sansone SA, Rocca-Serra P, Field D, Maguire E, Taylor C, Hofmann O, et al. Toward interoperable bioscience data. Nat Genet 2012;44:121-6.
15. Collins FS, Tabak LA. NIH plans to enhance reproducibility. Nature 2014;505:612-3.
16. Alberts B, Kirschner MW, Tilghman S, Varmus H. Rescuing US biomedical research from its systemic flaws. Proc Natl Acad Sci U S A 2014;111:5773-7.
17. Steen RG, Casadevall A, Fang FC. Why has the number of scientific retractions increased? PLoS ONE 2013;8:e68397.
18. Casadevall A, Fang FC. Reforming science: methodological and cultural reforms. Infect Immun 2012;80:891-6.
19. Hartshorne JK, Schachner A. Tracking replicability as a method of post-publication open evaluation. Front Comput Neurosci 2012;6:1-13.
20. Kapoor S, Sikka P, Saxena K. Publication of research article: an art or science? Ann Med Health Sci Res 2013;3:96-8.
21. Ioannidis JPA. Why most published research findings are false. PLoS Med 2005;2:e124.
22. Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet 2014;383:166-75.
23. Hirst A, Altman DG. Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. PLoS ONE 2012;7:e35621.
24. Little RR, Rohlfing CL, Sacks DB. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 2011;57:205-14.
25. Capes-Davis A, Reid YA, Kline MC, Storts DR, Strauss E, Dirks WG, et al. Match criteria for human cell line authentication: where do we draw the line? Int J Cancer 2013;132:2510-9.
26. Capes-Davis A, Theodosopoulos G, Atkin I, Drexler HG, Kohara A, MacLeod RA, et al. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer 2010;127:1-8.
27. Boonstra JJ, van Marion R, Beer DG, Lin L, Chaves P, Ribeiro C, et al. Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst 2010;102:271-4.
28. ATCC/SDO. ASN-0002: Authentication of human cell lines: standardization of STR profiling. Manassas, Virginia: ATCC-Standards Development Organization (SDO); 2012.
29. Editorial. Announcement: reducing our irreproducibility. Nature 2013;496.
30. Helsby MA, Fenn JR, Chalmers AD. Reporting research antibody use: how to increase experimental reproducibility. F1000 Res 2013;2:153.
31. Inglese J, Shamu CE, Guy RK. Reporting data from high-throughput screening of small-molecule libraries. Nat Chem Biol 2007;3:438-41.
32. McGovern SL, Caselli E, Grigorieff N, Shoichet BK. A common mechanism underlying promiscuous inhibitors from virtual and highthroughput screening. J Med Chem 2002;45:1712-22.
33. Auld DS, Thorne N, Maguire WF, Inglese J. Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. Proc Natl Acad Sci U S A 2009;106:3585-90.
34. McElroy SP, Nomura T, Torrie LS, Warbrick E, Gartner U, Wood G, et al. A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays. PLoS Biol 2013;11:e1001593.
35. Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature 2007;447:87-91.
36. Sheridan C. Doubts raised over "read-through" Duchenne drug mechanism. Nat Biotechnol 2013;31:771-3.
37. Cheng KC, Inglese J. A coincidence reporter-gene system for highthroughput screening. Nat Methods 2012;9:937.
38. Loscalzo J. Irreproducible experimental results: causes, (mis) interpretations, and consequences. Circulation 2012;125:1211-4.